Kilpatrick Townsend hires litigation team from DLA Piper

Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Cozen O'Connor snaps up Kilpatrick Townsend duo

28 October 2020 Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.

Big Pharma

Fed Circuit refuses Amgen unit appeal in win for Sanofi

15 October 2020 The US Court of Appeals for the Federal Circuit has dismissed Immunex’s appeal against a decision invalidating its patent on treating inflammatory disorders.

Biotechnology

Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms

6 October 2020 Regeneron Pharmaceuticals is facing claims that its “antibody cocktail”, which was administered to President Donald Trump to treat his COVID-19 symptoms, was developed with the unauthorised use of a fluorescent protein.

More on this story

Americas

Cozen O'Connor snaps up Kilpatrick Townsend duo

28 October 2020 Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.

Big Pharma

Fed Circuit refuses Amgen unit appeal in win for Sanofi

15 October 2020 The US Court of Appeals for the Federal Circuit has dismissed Immunex’s appeal against a decision invalidating its patent on treating inflammatory disorders.

Biotechnology

Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms

More on this story

Americas

Cozen O'Connor snaps up Kilpatrick Townsend duo

28 October 2020 Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.

Big Pharma

Fed Circuit refuses Amgen unit appeal in win for Sanofi

15 October 2020 The US Court of Appeals for the Federal Circuit has dismissed Immunex’s appeal against a decision invalidating its patent on treating inflammatory disorders.

Biotechnology

Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms